Literature DB >> 32925345

Incidence of and Factors Associated With Prolonged and Persistent Postoperative Opioid Use in Children 0-18 Years of Age.

Andrew Ward1, Elizabeth De Souza2, Daniel Miller1, Ellen Wang2, Eric C Sun2,3, Nicholas Bambos1,4, T Anthony Anderson2.   

Abstract

BACKGROUND: Long-term opioid use has negative health care consequences. Opioid-naïve adults are at risk for prolonged and persistent opioid use after surgery. While these outcomes have been examined in some adolescent and teenage populations, little is known about the risk of prolonged and persistent postoperative opioid use after common surgeries compared to children who do not undergo surgery and factors associated with these issues among pediatric surgical patients of all ages.
METHODS: Using a national administrative claims database, we identified 175,878 surgical visits by opioid-naïve children aged ≤18 years who underwent ≥1 of the 20 most common surgeries from each of 4 age groups between December 31, 2002, and December 30, 2017, and who filled a perioperative opioid prescription 30 days before to 14 days after surgery. Prolonged opioid use after surgery (filling ≥1 opioid prescription 90-180 days after surgery) was compared to a reference sample of 1,354,909 nonsurgical patients randomly assigned a false "surgery" date. Multivariable logistic regression models were used to estimate the association of surgical procedures and 22 other variables of interest with prolonged opioid use and persistent postoperative opioid use (filling ≥60 days' supply of opioids 90-365 days after surgery) for each age group.
RESULTS: Prolonged opioid use after surgery occurred in 0.77%, 0.76%, 1.00%, and 3.80% of surgical patients ages 0-<2, 2-<6, 6-<12, and 12-18, respectively. It was significantly more common in surgical patients than in nonsurgical patients (ages 0-<2: odds ratio [OR] = 4.6 [95% confidence interval (CI), 3.7-5.6]; ages 2-<6: OR = 2.5 [95% CI, 2.1-2.8]; ages 6-<12: OR = 2.1 [95% CI, 1.9-2.4]; and ages 12-18: OR = 1.8 [95% CI, 1.7-1.9]). In the multivariable models for ages 0-<12 years, few surgical procedures and none of the other variables of interest were associated with prolonged opioid use. In the models for ages 12-18 years, 10 surgical procedures and 5 other variables of interest were associated with prolonged opioid use. Persistent postoperative opioid use occurred in <0.1% of patients in all age groups.
CONCLUSIONS: Some patient characteristics and surgeries are positively and negatively associated with prolonged opioid use in opioid-naïve children of all ages, but persistent opioid use is rare. Specific pediatric subpopulations (eg, older patients with a history of mood/personality disorder or chronic pain) may be at markedly higher risk.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32925345      PMCID: PMC7723784          DOI: 10.1213/ANE.0000000000004823

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   6.627


  31 in total

1.  Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain.

Authors:  Randall T Brown; Megan Zuelsdorff; Michael Fleming
Journal:  J Opioid Manag       Date:  2006 May-Jun

2.  Physicians Prescribe More Opioid Than Needed to Treat Pain in Children After Outpatient Urological Procedures: An Observational Cohort Study.

Authors:  Joann B Hunsberger; Aaron Hsu; Myron Yaster; Paul T Vozzo; Shuna Gao; Elizabeth D White; Gayane Yenokyan; Barbara Vickers; Constance L Monitto
Journal:  Anesth Analg       Date:  2020-09       Impact factor: 5.108

Review 3.  American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients.

Authors:  Christopher L Wu; Adam B King; Timothy M Geiger; Michael C Grant; Michael P W Grocott; Ruchir Gupta; Jennifer M Hah; Timothy E Miller; Andrew D Shaw; Tong J Gan; Julie K M Thacker; Michael G Mythen; Matthew D McEvoy
Journal:  Anesth Analg       Date:  2019-08       Impact factor: 5.108

4.  Ambulatory Surgery Data From Hospitals and Ambulatory Surgery Centers: United States, 2010.

Authors:  Margaret J Hall; Alexander Schwartzman; Jin Zhang; Xiang Liu
Journal:  Natl Health Stat Report       Date:  2017-02

5.  Patterns and predictors of persistent opioid use following hip or knee arthroplasty.

Authors:  S C Kim; N Choudhry; J M Franklin; K Bykov; M Eikermann; J Lii; M A Fischer; B T Bateman
Journal:  Osteoarthritis Cartilage       Date:  2017-04-19       Impact factor: 6.576

6.  REDUCTION OF POSTOPERATIVE PAIN BY ENCOURAGEMENT AND INSTRUCTION OF PATIENTS. A STUDY OF DOCTOR-PATIENT RAPPORT.

Authors:  L D EGBERT; G E BATTIT; C E WELCH; M K BARTLETT
Journal:  N Engl J Med       Date:  1964-04-16       Impact factor: 91.245

7.  Defining Optimal Length of Opioid Pain Medication Prescription After Common Surgical Procedures.

Authors:  Rebecca E Scully; Andrew J Schoenfeld; Wei Jiang; Stuart Lipsitz; Muhammad Ali Chaudhary; Peter A Learn; Tracey Koehlmoos; Adil H Haider; Louis L Nguyen
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 14.766

8.  Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period.

Authors:  Eric C Sun; Beth D Darnall; Laurence C Baker; Sean Mackey
Journal:  JAMA Intern Med       Date:  2016-09-01       Impact factor: 44.409

Review 9.  Adolescent neurocognitive development and impacts of substance use: Overview of the adolescent brain cognitive development (ABCD) baseline neurocognition battery.

Authors:  M Luciana; J M Bjork; B J Nagel; D M Barch; R Gonzalez; S J Nixon; M T Banich
Journal:  Dev Cogn Neurosci       Date:  2018-02-21       Impact factor: 6.464

10.  Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study.

Authors:  Gabriel A Brat; Denis Agniel; Andrew Beam; Brian Yorkgitis; Mark Bicket; Mark Homer; Kathe P Fox; Daniel B Knecht; Cheryl N McMahill-Walraven; Nathan Palmer; Isaac Kohane
Journal:  BMJ       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.